Chris Daero Lee
About Chris Daero Lee
Chris Daero Lee is the Sr. Director, Strategic Product Leader for CAR T at Bristol Myers Squibb in Summit, New Jersey, with extensive experience in CMC development of biologics and a strong background in chemical engineering.
Current Position at Bristol Myers Squibb
Chris Daero Lee currently serves as Sr. Director, Strategic Product Leader - CAR T at Bristol Myers Squibb in Summit, New Jersey, United States. In this role, he is responsible for developing and driving the cell therapy franchise-level integrated product lifecycle management strategy. This includes ensuring end-to-end supply assurance and aligning product strategies with commercial objectives. His work involves close collaboration with Commercial and Development Program Teams to maximize value for CAR T products.
Previous Roles at Bristol Myers Squibb
Chris Daero Lee has held multiple positions at Bristol Myers Squibb, showcasing his extensive experience in the biopharmaceutical industry. From 2020 to 2021, he served as Director, Strategy and Business Operations in Cell Therapy MS&T. Prior to that, he was the CMC Development Team Leader from 2015 to 2020, responsible for leading projects from pre-clinical development through commercial product launch. Before these roles, he worked as Principal Engineer II in Biologics/Sterile Drug Product MS&T from 2005 to 2015, contributing significantly to biologics and small molecule development.
Educational Background
Chris Daero Lee has a strong academic background in engineering and business. He earned a Master of Business Administration (MBA) from NYU Stern School of Business between 2017 and 2019. He also holds a Master of Science (M.S.) in Chemical and Biochemical Engineering from Rutgers University and a Bachelor of Science (B.S.) in Chemical Engineering from Penn State University. Additionally, he has obtained a professional engineering (P.E.) license in chemical engineering.
Expertise in Biopharmaceutical Development
Chris Daero Lee is known for his extensive expertise in CMC (Chemistry, Manufacturing, and Controls) development, particularly in the areas of biologics, cell therapy, and small molecules. He has a proven track record of successfully leading projects through all stages of development, from pre-clinical to commercial product launch and lifecycle management. His innovative approaches and problem-solving skills have made him a valuable asset in the biopharmaceutical industry.
Product Strategy and Lifecycle Management
One of Chris Daero Lee's key roles at Bristol Myers Squibb involves developing a multi-year product strategy for CAR T products. This strategy ensures end-to-end supply assurance and alignment with the company's commercial strategy. He also drives integrated product lifecycle management strategies to maximize the value of cell therapy products in partnership with the Commercial and Development Program Teams. His strategic vision and collaboration skills have been instrumental in positioning Bristol Myers Squibb as a leader in the cell therapy field.